Delivery Order SPE2DB20D1051-SPE2DB24FD8DF
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,854.22 firm fixed-price delivery order is for the supply of 1,000 units of the medication Tamsulosin HCL 0.4 mg capsules. The contract has an ultimate completion date of September 16, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a firm-fixed price delivery order contract worth $9,139.98 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 1,000 units of Tamsulosin HCl 0.4 mg capsules. The contract has an ultimate completion date of March 6, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as the primary vehicle for providing...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,778.86 Firm Fixed Price contract is for the supply of 4,567,152,479 units of Tamsulosin HCL 0.4 mg capsules. The contract has a completion date of February 5, 2025 and was awarded on February 4, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,337.07 firm fixed-price delivery order is for the supply of 4,567,866,899 units of the prescription medication Tamsulosin HCL 0.4 mg capsules. The contract has an ultimate completion date of April 11, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a leading global pharmaceutical distributor, to provide 4,563,628,875 units of Tamsulosin HCl 0.4 mg capsules. The $3,049.48 order has a completion date of February 13, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division based in Conshohocken, Pennsylvania, is the prime contractor. This delivery order is part of a larger indefinite...
- This federal contract award is a $1,815.46 Firm Fixed Price delivery order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,563,500 capsules of Tamsulosin HCl 0.4 mg. The award has an ultimate completion date of February 1, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that serves as a vendor for federal healthcare programs, particularly within military and veterans' healthcare. This award is part of a larger Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,723.34, is for the delivery of 1000 units of the prescription medication Tamsulosin HCL 0.4 mg capsules. This is a firm fixed-price delivery order contract with a completion date of June 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,712.04 firm fixed-price delivery order is for the supply of 1,000 units of Tamsulosin HCl 0.4 mg capsules, with a completion date of December 12, 2023. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,096.99, is for the delivery of 4,567,327,770 units of Tamsulosin HCL 0.4 mg capsules. The contract is a firm fixed-price delivery order with a completion date of February 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,562,163,970 units of the medication Tamsulosin HCL 0.4 mg capsules. The $5,049.72 firm fixed-price delivery order contract has an ultimate completion date of September 14, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for a comprehensive range of pharmaceutical...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB24FD8DFDelivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,554.64 firm fixed price delivery order is for the supply of 4,564,702,627 units of the medication Tamsulosin HCl 0.4 mg capsules. The contract has an ultimate completion date of May 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is part of that larger IDC contract. There is no set-aside designation for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 5/23/24 |